Conversion from standard cyclosporine to Neoral in lung transplant recipients.
Kesten
S
S
Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA.
Scavuzzo
M
M
Laurin
L
L
Tan
A
A
Chaparro
C
C
D000284:Administration, Oral; D000704:Analysis of Variance; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D006207:Half-Life; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D007262:Infusions, Intravenous; D016040:Lung Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine